These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38907084)

  • 1. Peripheral Blood miRNA Expression in Patients with Essential Hypertension in the Han Chinese Population in Hefei, China.
    Cheng B; Yang R; Xu H; Wang L; Jiang N; Song T; Dong C
    Biochem Genet; 2024 Jun; ():. PubMed ID: 38907084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioinformatics analysis of the microRNA expression profile in the peripheral blood lymphocytes of Kazakh patients with essential hypertension in Xinjiang].
    Wang Y; Zhang L; Yang R; Shan LY; Wang L; Zhang YY; Li XZ; Ma KT
    Sheng Li Xue Bao; 2022 Oct; 74(5):751-762. PubMed ID: 36319098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
    [No Abstract]   [Full Text] [Related]  

  • 4. MiRNA expression profiles in healthy OSAHS and OSAHS with arterial hypertension: potential diagnostic and early warning markers.
    Yang X; Niu X; Xiao Y; Lin K; Chen X
    Respir Res; 2018 Oct; 19(1):194. PubMed ID: 30285853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
    Shin B; Lee JY; Im Y; Yoo H; Park J; Lee JS; Lee KY; Jeon K
    J Intensive Care; 2023 Aug; 11(1):35. PubMed ID: 37537685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis.
    Liguori M; Nuzziello N; Introna A; Consiglio A; Licciulli F; D'Errico E; Scarafino A; Distaso E; Simone IL
    Front Mol Neurosci; 2018; 11():288. PubMed ID: 30210287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment.
    Toyama K; Kiyosawa N; Watanabe K; Ishizuka H
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment.
    Ornello R; Zelli V; Compagnoni C; Caponnetto V; De Matteis E; Tiseo C; Tessitore A; Sacco S
    J Headache Pain; 2024 May; 25(1):80. PubMed ID: 38755568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel circulating miRNAs biomarkers for healthy obese and lean children.
    Ma F; Cao D; Liu Z; Li Y; Ouyang S; Wu J
    BMC Endocr Disord; 2023 Oct; 23(1):238. PubMed ID: 37904219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic potential of miR-200 family members in gingival crevicular fluid for chronic periodontitis: correlation with clinical parameters and therapeutic implications.
    Yu SL
    BMC Oral Health; 2023 Jul; 23(1):532. PubMed ID: 37525201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression Analysis of miRNA Profiles in Apheresis Platelets during Storage].
    Wang YQ; Zhuang YL; Qiao MM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):256-263. PubMed ID: 35123637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening miRNAs for early diagnosis of colorectal cancer by small RNA deep sequencing and evaluation in a Chinese patient population.
    Wang X; Chen L; Jin H; Wang S; Zhang Y; Tang X; Tang G
    Onco Targets Ther; 2016; 9():1159-66. PubMed ID: 27022275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA profiling of human nasopharyngeal carcinoma cell lines HONE1 and CNE2 after X-ray therapy.
    Luo H; Zhong F; Jing X; Lin H; Li Y
    Adv Clin Exp Med; 2022 Jun; 31(6):671-687. PubMed ID: 35275451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel prognostic and predictive microRNA targets for triple-negative breast cancer.
    Turashvili G; Lightbody ED; Tyryshkin K; SenGupta SK; Elliott BE; Madarnas Y; Ghaffari A; Day A; Nicol CJB
    FASEB J; 2018 May; ():fj201800120R. PubMed ID: 29812973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.